BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26729432)

  • 1. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
    Boero IJ; Paravati AJ; Xu B; Cohen EE; Mell LK; Le QT; Murphy JD
    J Clin Oncol; 2016 Mar; 34(7):684-90. PubMed ID: 26729432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.
    Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA
    Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer.
    Yu JB; Soulos PR; Sharma R; Makarov DV; Decker RH; Smith BD; Desai RA; Cramer LD; Gross CP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e101-7. PubMed ID: 22342095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Beadle BM; Liao KP; Giordano SH; Garden AS; Hutcheson KA; Lai SY; Guadagnolo BA
    Cancer; 2017 Jan; 123(2):283-293. PubMed ID: 27662641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Oncologist Characteristics and their Association with Outcomes in Patients with Head and Neck Cancer.
    Jain S; Popple R; Szychowski J; Sen B; Locher JL; Kilgore ML
    Pract Radiat Oncol; 2019 May; 9(3):e322-e330. PubMed ID: 30659934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma.
    Pollom EL; Wang G; Harris JP; Koong AC; Bendavid E; Bhattacharya J; Chang DT
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):177-185. PubMed ID: 28258896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IMRT experience of radiation oncologists and prognosis in head-and-neck cancer].
    Dunst J
    Strahlenther Onkol; 2016 Jun; 192(6):422-4. PubMed ID: 27169392
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.
    Amarasena I; Herschtal A; D'Costa I; Fua T; Tiong A; Geddes V; Tran P; Liu C; Corry J
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):541-546. PubMed ID: 28581395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
    Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
    Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Lin SH; Zhang N; Godby J; Wang J; Marsh GD; Liao Z; Komaki R; Ho L; Hofstetter WL; Swisher SG; Mehran RJ; Buchholz TA; Elting LS; Giordano SH
    Cancer; 2016 Mar; 122(6):917-28. PubMed ID: 26716915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort.
    Guadagnolo BA; Liu CC; Cormier JN; Du XL
    Cancer; 2010 Jul; 116(14):3505-12. PubMed ID: 20564123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of introducing intensity modulated radiotherapy into routine clinical practice.
    Miles EA; Clark CH; Urbano MT; Bidmead M; Dearnaley DP; Harrington KJ; A'Hern R; Nutting CM
    Radiother Oncol; 2005 Dec; 77(3):241-6. PubMed ID: 16298002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis.
    Jiang L; Zhang Y; Yang Z; Liang F; Wu J; Wang R
    Medicine (Baltimore); 2019 Aug; 98(34):e16942. PubMed ID: 31441887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on radiation therapy in head and neck cancers.
    Mazzola R; Fiorentino A; Ricchetti F; Gregucci F; Corradini S; Alongi F
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):359-364. PubMed ID: 29485913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy quality assurance in head and neck radiotherapy - Moving forward.
    McDowell L; Corry J
    Oral Oncol; 2019 Jan; 88():180-185. PubMed ID: 30616792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMRT for head and neck cancer: Cost implications.
    Razfar A; Mundi J; Grogan T; Lee S; Elashoff D; Abemayor E; St John M
    Am J Otolaryngol; 2016; 37(6):479-483. PubMed ID: 27968955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy.
    O'Neill M; Heron DE; Flickinger JC; Smith R; Ferris RL; Gibson M
    Am J Clin Oncol; 2011 Oct; 34(5):478-82. PubMed ID: 21537150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
    Mayo ZS; Ilori EO; Matia B; Smile TD; Fleming CW; Reddy CA; Scharpf J; Lamarre ED; Prendes BL; Ku J; Burkey BB; Joshi NP; Woody NM; Koyfman SA; Campbell SR
    Anticancer Res; 2022 Apr; 42(4):1845-1849. PubMed ID: 35347002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.